BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 30982765)

  • 1. MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway.
    Chu CA; Lee CT; Lee JC; Wang YW; Huang CT; Lan SH; Lin PC; Lin BW; Tian YF; Liu HS; Chow NH
    EBioMedicine; 2019 May; 43():270-281. PubMed ID: 30982765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H; Fesler A; Ba Y; Wu S; Ju J
    Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer.
    Lam CS; Ng L; Chow AK; Wan TM; Yau S; Cheng NS; Wong SK; Man JH; Lo OS; Foo DC; Poon JT; Pang RW; Law WL
    Oncotarget; 2017 Apr; 8(16):26858-26870. PubMed ID: 28460469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
    Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
    EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility.
    Zhuang M; Zhao S; Jiang Z; Wang S; Sun P; Quan J; Yan D; Wang X
    EBioMedicine; 2019 Mar; 41():286-298. PubMed ID: 30797712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
    Xin H; Wang C; Liu Z
    BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
    Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
    Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT2, a direct target of miR-212-5p, suppresses the proliferation and metastasis of colorectal cancer cells.
    Du F; Li Z; Zhang G; Shaoyan S; Geng D; Tao Z; Qiu K; Liu S; Zhou Y; Zhang Y; Gu J; Wang G; Li L; Wu W
    J Cell Mol Med; 2020 Sep; 24(17):9985-9998. PubMed ID: 32697380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1.
    Song M; Yin Y; Zhang J; Zhang B; Bian Z; Quan C; Zhou L; Hu Y; Wang Q; Ni S; Fei B; Wang W; Du X; Hua D; Huang Z
    Protein Cell; 2014 Nov; 5(11):851-61. PubMed ID: 25149074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircHIPK3 promotes colorectal cancer cells proliferation and metastasis via modulating of miR-1207-5p/FMNL2 signal.
    Yan Y; Su M; Qin B
    Biochem Biophys Res Commun; 2020 Apr; 524(4):839-846. PubMed ID: 32046858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK.
    Qin J; Luo M
    FEBS Lett; 2014 Jan; 588(1):99-104. PubMed ID: 24269686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC).
    Zhang T; Cai X; Li Q; Xue P; Chen Z; Dong X; Xue Y
    Oncotarget; 2016 Jul; 7(27):42225-42240. PubMed ID: 27302926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A.
    Yin Y; Zhang B; Wang W; Fei B; Quan C; Zhang J; Song M; Bian Z; Wang Q; Ni S; Hu Y; Mao Y; Zhou L; Wang Y; Yu J; Du X; Hua D; Huang Z
    Clin Cancer Res; 2014 Dec; 20(23):6187-99. PubMed ID: 25294901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity.
    Kim CW; Oh ET; Kim JM; Park JS; Lee DH; Lee JS; Kim KK; Park HJ
    Cancer Lett; 2018 Mar; 416():31-41. PubMed ID: 29247825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.
    Yu L; Lu Y; Han X; Zhao W; Li J; Mao J; Wang B; Shen J; Fan S; Wang L; Wang M; Li L; Tang J; Song B
    Stem Cell Res Ther; 2016 Dec; 7(1):180. PubMed ID: 27906093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5.
    Stiegelbauer V; Vychytilova-Faltejskova P; Karbiener M; Pehserl AM; Reicher A; Resel M; Heitzer E; Ivan C; Bullock M; Ling H; Deutsch A; Wulf-Goldenberg A; Adiprasito JB; Stoeger H; Haybaeck J; Svoboda M; Stotz M; Hoefler G; Slaby O; Calin GA; Gerger A; Pichler M
    Clin Cancer Res; 2017 Sep; 23(17):5255-5266. PubMed ID: 28533224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.